image_pdfimage_print
4 12, 2023

HB 2207

To The Extent Allowed By Federal Law, A Hospital Service Corporation Or Medical Service Corporation That Issues, Amends, Delivers Or Renews A Subscription Contract On Or After The Effective Date Of This Section Shall Provide Reimbursement Coverage To A Pharmacist At A Rate Not Less Than The Rate Provided To The Following: 1. A Physician Who Is Licensed Pursuant To Title 32, Chapter 13 Or 17. 2. A Nurse Practitioner Who Is Licensed Pursuant To Title 32, Chapter 15. 3. A Physician Assistant Who Is Licensed Pursuant To Title 32, Chapter 25.

HB 2207
4 12, 2023

SB 1382

Effective January 1, 2025, requires a pharmacy benefit manager (PBM) to apply for, obtain and maintain a valid certificate of authority (certificate) to operate as a PBM in Arizona and outlines certification requirements. Requires a PBM to provide a reasonably adequate and accessible retail PBM network for the distribution of prescription drugs.

SB 1382
4 12, 2023

SB 1248

Removes the requirement that health professional groups proposing to increase the scope of practice of a state-regulated health profession must complete a statutory sunrise review. Status: Vetoed by Governor.

SB 1248
4 12, 2023

SB 1216

Establishes that the total price a subscriber must pay for a covered prescription insulin drug to be limited to $35 for a 30 day supply. Status: Vetoed by Governor.

SB 1216
11 08, 2023

SB 1603

Directs licensed hospitals to comply with federal hospital price transparency regulations and demonstrate its compliance to the Arizona Department of Health Services (DHS). Subjects noncompliant hospitals to a civil penalty.

SB 1603
11 08, 2023

HB 2529 (replaced by SB 1248)

Removes the requirement that health professional groups proposing to increase the scope of practice of a state-regulated health profession must complete a statutory sunrise review

HB 2529 (replaced by SB 1248)
25 04, 2023

HB 2112

An act amending Title 36, Arizona revised statutes, by adding chapter 42; relating to prescription drugs. Defines unconscionable increase to mean that an increase in the price of a prescription drug that both: (a) Is excessive and not justified by the cost of producing the drug or the cost of appropriate expansion of access to the drug to promote public health. And (b) Results in consumers for whom the drug has been prescribed having no meaningful choice about whether to purchase the drug at an excessive price because of the importance of the drug [...]

HB 2112
25 07, 2022

SB 1088

A health care facility with more than fifty inpatient beds must make available on request or online the direct pay price for at least the fifty most used diagnosis-related group codes, if applicable, for the facility and at least the fifty most used outpatient service codes, if applicable, for the facility. The services may be identified by a common procedural terminology code or by a plain-English description. The health care facility must update the direct pay prices at least annually based on the services from a twelve-month period that occurred within the eighteen-month period [...]

SB 1088